Minakawa K, Ono S, Watanabe M, Sato Y, Suzuki S, Odawara S, Kawabata K, Ueda K, Nollet KE, Sano H, Ikezoe T, Kikuta A, Ikeda K*. Evaluation of a quantitative PCR-based method for chimerism analysis of Japanese donor/recipient pairs. Scientific Reports. 2022;12:21328. (doi: 10.1038/s41598-022-25878-9)
Ikeda K*, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Comparison of cryoprotectants in hematopoietic cell infusion–related adverse events. Transfusion. 2022;62(6):1280-1288. doi: 10.1111/TRF.16877
Sano H, Mochizuki K, Kobayashi S, Ohara Y, Takahashi N, Kudo S, Ikeda K, Ohto H, Kikuta A. T-cell replete haploidentical stem cell transplantation with low dose anti-thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors. Cancer Reports. 2022;5(7):e1519.
Kobayashi S, Sano, H, Mochizuki K, Ohara Y, Takahashi N, Kudo S, Ikeda K, Ohto H, Kikuta A. Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation. International Journal of Hematology. 2022;115(3):414-423.
三村耕作、伊藤美郷、中嶋正太郎、岡山洋和、齋藤元伸、門馬智之、佐瀬善一郎、河野浩二.CD163陽性M2腫瘍関連マクロファージとPD-1を標的とした複合がん免疫療法の開発(The development of combinatorial immunotherapy targeting CD163-positive M2 tumor-associated macrophages and PD-1) 第122回日本外科学会定期学術集会(2022/4/14-16 熊本市)
三村耕作、中嶋正太郎、多田武志、渡辺洋平、早瀬傑、佐瀬善一郎、河野浩二.Development of combination cancer immunotherapy for patients with advanced esophageal squamous cell carcinoma(進行食道扁平上皮癌症例における複合がん免疫療法の開発) 第77回日本消化器外科学会総会(2022/7/20-22 横浜市)
三村耕作、伊藤美郷、中嶋正太郎、小野澤寿志、岡山洋和、藤田正太郎、坂本渉、齋藤元伸、門馬智之、河野浩二.The mechanisms of increased frequency of M2 tumor-associated macrophages infiltration in the colorectal cancer tumor microenvironment (大腸癌腫瘍微小環境におけるM2腫瘍関連マクロファージの浸潤頻度増加機序について)第60回日本癌治療学会学術集会(2022/10/20-22 神戸市)